FMP

FMP

Enter

CHAQ - Chardan Healthcare A...

photo-url-https://images.financialmodelingprep.com/symbol/CHAQ.png

Chardan Healthcare Acquisition 2 Corp.

CHAQ

AMEX

Inactive Equity

Chardan Healthcare Acquisition 2 Corp. intends to acquire assets and businesses through a merger, share exchange, stock purchase, recapitalization, reorganization, or other similar business combination. The company was founded in 2018 and is based in New York, New York.

8.41 USD

-0.95 (-11.3%)

Latest CHAQ News

Business Wire

Sep 2, 2021

Renovacor, Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange

PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc. Closes its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange.

Read More

PRNewsWire

Sep 1, 2021

Chardan Healthcare Acquisition 2 Corp. Announces Stockholder Approval Of Business Combination With Renovacor, Inc.

NEW YORK, Sept. 1, 2021 /PRNewswire/ -- Chardan Healthcare Acquisition 2 Corp. (NYSE: CHAQ) ("CHAQ"), a special purpose acquisition company sponsored by Chardan Capital Markets ("Chardan"), today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 (the "Special Meeting"), regarding the proposed business combination with Renovacor, Inc. ("Renovacor"), an early‑stage biotechnology company developing adeno-associated...

Read More

PRNewsWire

Aug 25, 2021

Chardan Healthcare Acquisition 2 Corp. Announces Renovacor's Appointment of Matt Killeen, Ph.D., as Chief Scientific Officer

NEW YORK, Aug. 25, 2021 /PRNewswire/ -- Renovacor, Inc. ("Renovacor"), an early–stage biotechnology company developing adeno-associated virus (AAV)–based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants, today announced the appointment of Matt Killeen, Ph.D., as chief scientific officer (CSO), effective as of September 1, 2021.

Read More

GlobeNewsWire

Jul 12, 2021

Renovacor Announces the Appointment of Jiwen Zhang, Ph.D., as Senior Vice President, Regulatory Affairs and Quality Assurance

Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy Dr. Zhang has over 20 years of experience in regulatory affairs, with over a decade specifically in the field of cell and gene therapy

Read More

PRNewsWire

Mar 27, 2021

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Chardan Healthcare Acquisition 2 Corp. - CHAQ

NEW YORK, March 27, 2021 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating Chardan Healthcare Acquisition 2 Corp. ("CHAQ" or the "Company") (CHAQ) relating to its proposed merger Renovacor, Inc. Under the terms of the agreement, CHAQ will acquire Renovacor through a re...

Read More

seekingalpha

Oct 18, 2020

U.S. IPO Weekly Recap: Solar Technology Shines In A 9-IPO Week

Nine IPOs and five SPACs went public this past week, and one IPO postponed. New filing activity continued to pump the brakes as we near the election, with just one new IPO filing.

Read More

seekingalpha

Sep 26, 2020

U.S. IPO Weekly Recap: Health And Tech Dominate The Calendar In An 11 IPO Week

September activity remained high as 11 IPOs and eight SPACs went public this past week. The IPO market shows no signs of slowing with eight IPOs and 18 SPACS submitting initial filings.

Read More

https://www.fool.com

Aug 7, 2019

Kamada Ltd. (KMDA) Q2 2019 Earnings Call Transcript | The Motley Fool

KMDA earnings call for the period ending June 30, 2019.

Read More

https://www.marketwatch.com

Mar 2, 2019

Why Big Pharma Is Diving Into Gene Therapy

Emerging revolutionary treatments promise possible cures for diseases like hemophilia and muscular dystrophy—and opportunities for investors

Read More
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep